[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.145.220.120. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 1987

Thrombolytic Therapy of AxillarySubclavian Venous Thrombosis

Author Affiliations

From the Departments of Surgery (Drs Landercasper, Boyd, and Kisken), Cardiothoracic Surgery (Dr Gall), and Medicine (Drs Fischer, Dahlberg, and Boland), Gundersen Clinic, Ltd/La Crosse Lutheran Hospital, La Crosse, Wis.

Arch Surg. 1987;122(9):1072-1075. doi:10.1001/archsurg.1987.01400210110017
Abstract

• Patients with axillary-subclavian vein thrombosis often have a poor outcome when treated with intravenous heparin sodium and oral warfarin sodium. Four patients were therefore treated with thrombolytic therapy. Good initial and excellent long-term results were achieved. In follow-up that has ranged up to four years, these patients do not have the common complaints of edema, fatigue, cramping, or weakness seen after traditional anticoagulation. Patients have returned to their previous occupations and have normal arm function. Noninvasive Doppler vascular laboratory studies suggest continued patency of axillary veins. Thrombolytic therapy should be considered in the treatment of spontaneous axillarysubclavian vein thrombosis.

(Arch Surg 1987;122:1072-1075)

×